553 related articles for article (PubMed ID: 21971424)
21. Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery.
Sato Y; Note Y; Maeki M; Kaji N; Baba Y; Tokeshi M; Harashima H
J Control Release; 2016 May; 229():48-57. PubMed ID: 26995758
[TBL] [Abstract][Full Text] [Related]
22. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
Sato Y; Matsui H; Sato R; Harashima H
J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
[TBL] [Abstract][Full Text] [Related]
23. The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cells.
Uemura Y; Naoi T; Kanai Y; Kobayashi K
Pharm Dev Technol; 2019 Mar; 24(3):263-268. PubMed ID: 29688101
[TBL] [Abstract][Full Text] [Related]
24. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
[TBL] [Abstract][Full Text] [Related]
25. Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid.
Suzuki Y; Ishihara H
Int J Pharm; 2016 Aug; 510(1):350-8. PubMed ID: 27374199
[TBL] [Abstract][Full Text] [Related]
26. Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.
Ramezanpour M; Schmidt ML; Bodnariuc I; Kulkarni JA; Leung SSW; Cullis PR; Thewalt JL; Tieleman DP
Nanoscale; 2019 Aug; 11(30):14141-14146. PubMed ID: 31334542
[TBL] [Abstract][Full Text] [Related]
27. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery.
Alabi CA; Love KT; Sahay G; Yin H; Luly KM; Langer R; Anderson DG
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):12881-6. PubMed ID: 23882076
[TBL] [Abstract][Full Text] [Related]
29. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo.
Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A
J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.
Terada T; Kulkarni JA; Huynh A; Chen S; van der Meel R; Tam YYC; Cullis PR
Langmuir; 2021 Jan; 37(3):1120-1128. PubMed ID: 33439022
[TBL] [Abstract][Full Text] [Related]
31. Identification of a potent ionizable lipid for efficient macrophage transfection and systemic anti-interleukin-1β siRNA delivery against acute liver failure.
Ding F; Zhang H; Li Q; Yang C
J Mater Chem B; 2021 Jul; 9(25):5136-5149. PubMed ID: 34132324
[TBL] [Abstract][Full Text] [Related]
32. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
[TBL] [Abstract][Full Text] [Related]
33. Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs.
Yu B; Wang X; Zhou C; Teng L; Ren W; Yang Z; Shih CH; Wang T; Lee RJ; Tang S; Lee LJ
Pharm Res; 2014 Oct; 31(10):2685-95. PubMed ID: 24740244
[TBL] [Abstract][Full Text] [Related]
34. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
[TBL] [Abstract][Full Text] [Related]
35. Enhancing siRNA delivery by employing lipid nanoparticles.
Hope MJ
Ther Deliv; 2014 Jun; 5(6):663-73. PubMed ID: 25090280
[TBL] [Abstract][Full Text] [Related]
36. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
[TBL] [Abstract][Full Text] [Related]
37. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.
Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T
Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372
[TBL] [Abstract][Full Text] [Related]
38. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.
Kubota K; Onishi K; Sawaki K; Li T; Mitsuoka K; Sato T; Takeoka S
Int J Nanomedicine; 2017; 12():5121-5133. PubMed ID: 28790820
[TBL] [Abstract][Full Text] [Related]
39. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
[TBL] [Abstract][Full Text] [Related]
40. A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system.
Wang S; Wei X; Sun X; Chen C; Zhou J; Zhang G; Wu H; Guo B; Wei L
Int J Nanomedicine; 2018; 13():617-631. PubMed ID: 29440889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
